Now Feluda to detect Covid cases : Tata Group to launch India's CRISPR Covid Test

▴ Now Feluda to detect Covid cases : Tata Group to launch India's CRISPR Covid Test
FELUDA is actually an acronym - FNACS9 Editor Linked Uniform Detection Assay (FELUDA) – for an indigenous test for rapid diagnosis of Covid-19.

India’s first COVID-19 detecting paper strip ‘Feluda’ delivers results within minutes! One of the most pertinent questions going on in everyone’s head is if they are infected with Coronavirus but have no symptoms? In a matter of minutes, courtesy writer and film-maker Satyajit Ray’s popular fictional detective, ‘Feluda,’ could now clear all your doubts. The ‘Feluda’ is a paper-based test strip that detects the latest coronavirus in an hour, and can now be the solution to the urgent need for rapid testing in India, a LiveMint report indicates.

A team led by two scientists of Bengali descent, Dr. Souvik Maiti and Dr. Debojyoti Chakraborty, at the Institute of Genomics and Integrative Biology (CSIR-IGIB) of the Council of Science & Industrial Research in New Delhi, have come up with a simple strip-test to tell you if you have COVID-19 in minutes, a New18 report has stated. The study uses the state-of-the-art gene-editing tool-Crispr-Cas9 to target and identifies genomic sequences of the novel coronavirus in suspected individual samples.

The kit is similar to a compact paper-strip test used to confirm pregnancy and is much less complex and needs no specific professional expertise to perform. The team led by Dr Souvik Maiti and Dr Debjyoti Chakraborty is currently testing the package in a patient population for its accuracy and responsiveness and hopes to obtain approval within a week from an Indian Medical Research Council (ICMR) regulatory body.

Unlike the real-time PCR test currently being used for Covid-19 diagnosis in India, which costs about 4500, the paper-strip test costs less than 500. It also does not rely on expensive real-time PCR machines for RNA isolation, DNA conversion, and amplification which are already in limited supply, the News18 report indicated.

Although this method has been tested by scientists in other countries including Stanford University and the Massachusetts Institute of Technology (MIT), it is the first such indigenous test kit to be developed in India based on CRISPR technology.

This testing method can be a boon for India where lockdown is about to end and people will have to come back to work. The ability to know if they have Coronavirus infection or not will help firms and employees in decision making over the resumption of coming to the office for work.

Tags : #FeludaCovidTest #FNACS9EditorLinkedUniformDetectionAssay #StanfordUniversity #MIT #MadeInIndiaCovidTest #LatestCovidNewsUpdateSep21 #LatestCovidTestingNewsUpdateSep21

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024